Once we demonstrated that POU1F1 regulates LDHA and that pharmacological or genetic manipulation of LDHA induces phenotypic changes in breast cancer cells that modify cancer progression, we studied whether POU1F1 could have an impact on TME, specifically on fibroblasts. The gene discussed is LDHA; the disease is cancer.